Revolutionize Precision Oncology with QuantideX: Where Sensitivity Meets Scalability
Asuragen is committed to advancing precision oncology by delivering molecular solutions that empower confident decisions in both clinical and research settings. Our comprehensive portfolio — encompassing medical devices and research-use-only products — offers highly sensitive, accurate results through innovative, multiplexed workflows. The QuantideX suite is purpose-built for laboratory efficiency, featuring intuitive software that streamlines data reporting and automates complex calculations to minimize errors and maximize throughput, supporting reliable insights where they matter most.
With ready-to-use kits including pre-mixed, quality-controlled reagents, the QuantideX portfolio works to increase efficiency by reducing hands-on time and minimizing costs without sacrificing performance.
QuantideX qPCR ESR1 exoMutation Kit*
The Quantidex qPCR ESR1 exoMutation Kit is the first multi-analyte liquid biopsy assay tailored for detecting ESR1 mutations. Designed to provide highly sensitive detection in 11 of the most prevalent ESR1 variants in plasma, the kit offers a novel approach to achieving more meaningful breast cancer insights.
QuantideX Portfolio of Assays with High Sensitivity and Streamlined Workflow
QuantideX qPCR BCR-ABL IS Kit
QuantideX qPCR BCR-ABL IS Kit
The first FDA-cleared Chronic Myeloid Leukemia (CML) monitoring assay provides deep sensitivity exceeding the NCCN guidelines with a Limit of Detection of MR4.7. Its multiplex design reduces hands-on time and increases throughput for labs.
QuantideX qPCR BCR-ABL Minor Kit*
QuantideX qPCR BCR-ABL Minor Kit*
With a workflow similar to the BCR-ABL IS Kit, this assay allows labs to easily implement both assays to provide a more streamlined workflow.
*For Research Use Only. Not For Use in Diagnostic Procedures.